1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Personalized Medicine for Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Immunotherapy 1.2.3 Targeted Therapy 1.2.4 Chemotherapy 1.2.5 Hormone Therapy 1.2.6 Others 1.3 Market by Application 1.3.1 Global Personalized Medicine for Cancer Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Breast Cancer 1.3.3 Blood Cancer 1.3.4 Gastrointestinal Cancer 1.3.5 Prostate Cancer 1.3.6 Skin Cancer 1.3.7 Lung Cancer 1.3.8 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Personalized Medicine for Cancer Market Perspective (2017-2028) 2.2 Personalized Medicine for Cancer Growth Trends by Region 2.2.1 Personalized Medicine for Cancer Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Personalized Medicine for Cancer Historic Market Size by Region (2017-2022) 2.2.3 Personalized Medicine for Cancer Forecasted Market Size by Region (2023-2028) 2.3 Personalized Medicine for Cancer Market Dynamics 2.3.1 Personalized Medicine for Cancer Industry Trends 2.3.2 Personalized Medicine for Cancer Market Drivers 2.3.3 Personalized Medicine for Cancer Market Challenges 2.3.4 Personalized Medicine for Cancer Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Personalized Medicine for Cancer Players by Revenue 3.1.1 Global Top Personalized Medicine for Cancer Players by Revenue (2017-2022) 3.1.2 Global Personalized Medicine for Cancer Revenue Market Share by Players (2017-2022) 3.2 Global Personalized Medicine for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Personalized Medicine for Cancer Revenue 3.4 Global Personalized Medicine for Cancer Market Concentration Ratio 3.4.1 Global Personalized Medicine for Cancer Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine for Cancer Revenue in 2021 3.5 Personalized Medicine for Cancer Key Players Head office and Area Served 3.6 Key Players Personalized Medicine for Cancer Product Solution and Service 3.7 Date of Enter into Personalized Medicine for Cancer Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Personalized Medicine for Cancer Breakdown Data by Type 4.1 Global Personalized Medicine for Cancer Historic Market Size by Type (2017-2022) 4.2 Global Personalized Medicine for Cancer Forecasted Market Size by Type (2023-2028) 5 Personalized Medicine for Cancer Breakdown Data by Application 5.1 Global Personalized Medicine for Cancer Historic Market Size by Application (2017-2022) 5.2 Global Personalized Medicine for Cancer Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Personalized Medicine for Cancer Market Size (2017-2028) 6.2 North America Personalized Medicine for Cancer Market Size by Country (2017-2022) 6.3 North America Personalized Medicine for Cancer Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Personalized Medicine for Cancer Market Size (2017-2028) 7.2 Europe Personalized Medicine for Cancer Market Size by Country (2017-2022) 7.3 Europe Personalized Medicine for Cancer Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Personalized Medicine for Cancer Market Size (2017-2028) 8.2 Asia-Pacific Personalized Medicine for Cancer Market Size by Country (2017-2022) 8.3 Asia-Pacific Personalized Medicine for Cancer Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Personalized Medicine for Cancer Market Size (2017-2028) 9.2 Latin America Personalized Medicine for Cancer Market Size by Country (2017-2022) 9.3 Latin America Personalized Medicine for Cancer Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Personalized Medicine for Cancer Market Size (2017-2028) 10.2 Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2017-2022) 10.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Bayer 11.1.1 Bayer Company Detail 11.1.2 Bayer Business Overview 11.1.3 Bayer Personalized Medicine for Cancer Introduction 11.1.4 Bayer Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.1.5 Bayer Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Company Detail 11.2.2 GlaxoSmithKline Business Overview 11.2.3 GlaxoSmithKline Personalized Medicine for Cancer Introduction 11.2.4 GlaxoSmithKline Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.2.5 GlaxoSmithKline Recent Development 11.3 Novartis 11.3.1 Novartis Company Detail 11.3.2 Novartis Business Overview 11.3.3 Novartis Personalized Medicine for Cancer Introduction 11.3.4 Novartis Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.3.5 Novartis Recent Development 11.4 Sanofi 11.4.1 Sanofi Company Detail 11.4.2 Sanofi Business Overview 11.4.3 Sanofi Personalized Medicine for Cancer Introduction 11.4.4 Sanofi Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.4.5 Sanofi Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Detail 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Personalized Medicine for Cancer Introduction 11.5.4 Pfizer Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.5.5 Pfizer Recent Development 11.6 Amgen 11.6.1 Amgen Company Detail 11.6.2 Amgen Business Overview 11.6.3 Amgen Personalized Medicine for Cancer Introduction 11.6.4 Amgen Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.6.5 Amgen Recent Development 11.7 Merck 11.7.1 Merck Company Detail 11.7.2 Merck Business Overview 11.7.3 Merck Personalized Medicine for Cancer Introduction 11.7.4 Merck Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.7.5 Merck Recent Development 11.8 Bristol-Myers Squibb 11.8.1 Bristol-Myers Squibb Company Detail 11.8.2 Bristol-Myers Squibb Business Overview 11.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Introduction 11.8.4 Bristol-Myers Squibb Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.8.5 Bristol-Myers Squibb Recent Development 11.9 Ariad Pharmaceuticals (Takeda) 11.9.1 Ariad Pharmaceuticals (Takeda) Company Detail 11.9.2 Ariad Pharmaceuticals (Takeda) Business Overview 11.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Introduction 11.9.4 Ariad Pharmaceuticals (Takeda) Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.9.5 Ariad Pharmaceuticals (Takeda) Recent Development 11.10 Eli Lilly 11.10.1 Eli Lilly Company Detail 11.10.2 Eli Lilly Business Overview 11.10.3 Eli Lilly Personalized Medicine for Cancer Introduction 11.10.4 Eli Lilly Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.10.5 Eli Lilly Recent Development 11.11 Roche 11.11.1 Roche Company Detail 11.11.2 Roche Business Overview 11.11.3 Roche Personalized Medicine for Cancer Introduction 11.11.4 Roche Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.11.5 Roche Recent Development 11.12 Boehringer Ingelheim 11.12.1 Boehringer Ingelheim Company Detail 11.12.2 Boehringer Ingelheim Business Overview 11.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Introduction 11.12.4 Boehringer Ingelheim Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.12.5 Boehringer Ingelheim Recent Development 11.13 Johnson and Johnson 11.13.1 Johnson and Johnson Company Detail 11.13.2 Johnson and Johnson Business Overview 11.13.3 Johnson and Johnson Personalized Medicine for Cancer Introduction 11.13.4 Johnson and Johnson Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.13.5 Johnson and Johnson Recent Development 11.14 Teva Pharmaceuticals 11.14.1 Teva Pharmaceuticals Company Detail 11.14.2 Teva Pharmaceuticals Business Overview 11.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Introduction 11.14.4 Teva Pharmaceuticals Revenue in Personalized Medicine for Cancer Business (2017-2022) 11.14.5 Teva Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Personalized Medicine for Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Immunotherapy Table 3. Key Players of Targeted Therapy Table 4. Key Players of Chemotherapy Table 5. Key Players of Hormone Therapy Table 6. Key Players of Others Table 7. Global Personalized Medicine for Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Personalized Medicine for Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Personalized Medicine for Cancer Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Personalized Medicine for Cancer Market Share by Region (2017-2022) Table 11. Global Personalized Medicine for Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Personalized Medicine for Cancer Market Share by Region (2023-2028) Table 13. Personalized Medicine for Cancer Market Trends Table 14. Personalized Medicine for Cancer Market Drivers Table 15. Personalized Medicine for Cancer Market Challenges Table 16. Personalized Medicine for Cancer Market Restraints Table 17. Global Personalized Medicine for Cancer Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Personalized Medicine for Cancer Market Share by Players (2017-2022) Table 19. Global Top Personalized Medicine for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine for Cancer as of 2021) Table 20. Ranking of Global Top Personalized Medicine for Cancer Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Personalized Medicine for Cancer Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Personalized Medicine for Cancer Product Solution and Service Table 24. Date of Enter into Personalized Medicine for Cancer Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Personalized Medicine for Cancer Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Personalized Medicine for Cancer Revenue Market Share by Type (2017-2022) Table 28. Global Personalized Medicine for Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Personalized Medicine for Cancer Revenue Market Share by Type (2023-2028) Table 30. Global Personalized Medicine for Cancer Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Personalized Medicine for Cancer Revenue Market Share by Application (2017-2022) Table 32. Global Personalized Medicine for Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Personalized Medicine for Cancer Revenue Market Share by Application (2023-2028) Table 34. North America Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million) Table 35. North America Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million) Table 36. Europe Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million) Table 37. Europe Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million) Table 38. Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2017-2022) & (US$ Million) Table 39. Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2023-2028) & (US$ Million) Table 40. Latin America Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million) Table 41. Latin America Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million) Table 42. Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million) Table 43. Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million) Table 44. Bayer Company Detail Table 45. Bayer Business Overview Table 46. Bayer Personalized Medicine for Cancer Product Table 47. Bayer Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 48. Bayer Recent Development Table 49. GlaxoSmithKline Company Detail Table 50. GlaxoSmithKline Business Overview Table 51. GlaxoSmithKline Personalized Medicine for Cancer Product Table 52. GlaxoSmithKline Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 53. GlaxoSmithKline Recent Development Table 54. Novartis Company Detail Table 55. Novartis Business Overview Table 56. Novartis Personalized Medicine for Cancer Product Table 57. Novartis Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 58. Novartis Recent Development Table 59. Sanofi Company Detail Table 60. Sanofi Business Overview Table 61. Sanofi Personalized Medicine for Cancer Product Table 62. Sanofi Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 63. Sanofi Recent Development Table 64. Pfizer Company Detail Table 65. Pfizer Business Overview Table 66. Pfizer Personalized Medicine for Cancer Product Table 67. Pfizer Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 68. Pfizer Recent Development Table 69. Amgen Company Detail Table 70. Amgen Business Overview Table 71. Amgen Personalized Medicine for Cancer Product Table 72. Amgen Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 73. Amgen Recent Development Table 74. Merck Company Detail Table 75. Merck Business Overview Table 76. Merck Personalized Medicine for Cancer Product Table 77. Merck Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 78. Merck Recent Development Table 79. Bristol-Myers Squibb Company Detail Table 80. Bristol-Myers Squibb Business Overview Table 81. Bristol-Myers Squibb Personalized Medicine for Cancer Product Table 82. Bristol-Myers Squibb Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 83. Bristol-Myers Squibb Recent Development Table 84. Ariad Pharmaceuticals (Takeda) Company Detail Table 85. Ariad Pharmaceuticals (Takeda) Business Overview Table 86. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product Table 87. Ariad Pharmaceuticals (Takeda) Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 88. Ariad Pharmaceuticals (Takeda) Recent Development Table 89. Eli Lilly Company Detail Table 90. Eli Lilly Business Overview Table 91. Eli Lilly Personalized Medicine for Cancer Product Table 92. Eli Lilly Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 93. Eli Lilly Recent Development Table 94. Roche Company Detail Table 95. Roche Business Overview Table 96. Roche Personalized Medicine for CancerProduct Table 97. Roche Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 98. Roche Recent Development Table 99. Boehringer Ingelheim Company Detail Table 100. Boehringer Ingelheim Business Overview Table 101. Boehringer Ingelheim Personalized Medicine for CancerProduct Table 102. Boehringer Ingelheim Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 103. Boehringer Ingelheim Recent Development Table 104. Johnson and Johnson Company Detail Table 105. Johnson and Johnson Business Overview Table 106. Johnson and Johnson Personalized Medicine for CancerProduct Table 107. Johnson and Johnson Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 108. Johnson and Johnson Recent Development Table 109. Teva Pharmaceuticals Company Detail Table 110. Teva Pharmaceuticals Business Overview Table 111. Teva Pharmaceuticals Personalized Medicine for CancerProduct Table 112. Teva Pharmaceuticals Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million) Table 113. Teva Pharmaceuticals Recent Development Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Personalized Medicine for Cancer Market Share by Type: 2021 VS 2028 Figure 2. Immunotherapy Features Figure 3. Targeted Therapy Features Figure 4. Chemotherapy Features Figure 5. Hormone Therapy Features Figure 6. Others Features Figure 7. Global Personalized Medicine for Cancer Market Share by Application in 2021 & 2028 Figure 8. Breast Cancer Case Studies Figure 9. Blood Cancer Case Studies Figure 10. Gastrointestinal Cancer Case Studies Figure 11. Prostate Cancer Case Studies Figure 12. Skin Cancer Case Studies Figure 13. Lung Cancer Case Studies Figure 14. Others Case Studies Figure 15. Personalized Medicine for Cancer Report Years Considered Figure 16. Global Personalized Medicine for Cancer Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 17. Global Personalized Medicine for Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 18. Global Personalized Medicine for Cancer Market Share by Region: 2021 VS 2028 Figure 19. Global Personalized Medicine for Cancer Market Share by Players in 2021 Figure 20. Global Top Personalized Medicine for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine for Cancer as of 2021) Figure 21. The Top 10 and 5 Players Market Share by Personalized Medicine for Cancer Revenue in 2021 Figure 22. North America Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. North America Personalized Medicine for Cancer Market Share by Country (2017-2028) Figure 24. United States Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Canada Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Europe Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Europe Personalized Medicine for Cancer Market Share by Country (2017-2028) Figure 28. Germany Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. France Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. U.K. Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Italy Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Russia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Nordic Countries Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Personalized Medicine for Cancer Market Share by Region (2017-2028) Figure 36. China Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Latin America Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Latin America Personalized Medicine for Cancer Market Share by Country (2017-2028) Figure 44. Mexico Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Middle East & Africa Personalized Medicine for Cancer Market Share by Country (2017-2028) Figure 48. Turkey Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Saudi Arabia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Bayer Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 51. GlaxoSmithKline Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 52. Novartis Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 53. Sanofi Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 54. Pfizer Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 55. Amgen Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 56. Merck Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 58. Ariad Pharmaceuticals (Takeda) Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 59. Eli Lilly Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 60. Roche Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 61. Boehringer Ingelheim Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 62. Johnson and Johnson Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 63. Teva Pharmaceuticals Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Bayer GlaxoSmithKline Novartis Sanofi Pfizer Amgen Merck Bristol-Myers Squibb Ariad Pharmaceuticals (Takeda) Eli Lilly Roche Boehringer Ingelheim Johnson and Johnson Teva Pharmaceuticals